Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04690582 · ClinicalTrials.gov registry record · NA

Improving Treatment Outcomes for Suicidal Veterans With PTSD

A NA study of PTSD and Suicidal Ideation, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
157
Enrollment target
1
Study location

NCT04690582: Completed NA study of PTSD and Suicidal Ideation, sponsored by Ohio State University.

NCT04690582 is a NA study of PTSD and Suicidal Ideation that has completed, run by Ohio State University. The registered enrollment target is 157 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04690582, a NA study of PTSD and Suicidal Ideation, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
157 participants
Enrollment target
1
Study location

Study Summary

The efficacy of cognitive processing therapy (CPT) for reducing the symptoms of posttraumatic stress disorder (PTSD) across populations including military personnel and veterans is well supported. CPT also contributes to significant and rapid reductions in suicide ideation among people diagnosed with PTSD, although available evidence suggests this effect decays over time. Studies also show that approximately 1 in 6 people who begin CPT without suicide ideation will subsequently report suicidal thoughts at some point during or soon after completing treatment. Research focused on improving CPT's effects on suicide risk is therefore warranted. The primary aim of this study is to determine if the integration of a crisis response plan (CRP)--an empirically-supported procedure for reducing suicide ideation and attempts--can lead to faster reductions in suicide ideation among acutely suicidal veterans receiving CPT and prevent the development of suicide ideation among veterans who begin CPT without suicide ideation.

Primary Outcome

Suicide ideation will be measured using the Scale for Suicide Ideation, an empirically-supported self-report scale that assesses the intensity of suicide-related thoughts, urges, intentions, and behaviors. Scores range from 0 to 38, with higher scores indicating more severe suicide ideation.

Interventions

  • BEHAVIORAL Cognitive Processing Therapy (CPT)
  • BEHAVIORAL Narrative Assessment
  • BEHAVIORAL Crisis Response Plan (CRP)
  • BEHAVIORAL Safety Planning Intervention (SPI)

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 157 participants
Start Date 2021-01-15
Est. Completion 2023-12-31
Phase NA
Ohio State University

552 total trials

What the finished NCT04690582 record still lists

NCT04690582 is an interventional study that assigns participants to a tested intervention. The registered 157 participants enrollment target is mid-sized for trials with a published cap, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (48% lower).

The record links to 3 conditions, with PTSD appearing as the primary indexed condition, and to 4 interventions - of which Cognitive Processing Therapy (CPT) is the first listed.

NCT04690582 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT04690582 about?

NCT04690582 is a clinical study titled "Improving Treatment Outcomes for Suicidal Veterans With PTSD". The efficacy of cognitive processing therapy (CPT) for reducing the symptoms of posttraumatic stress disorder (PTSD) across populations including military personnel and veterans is well supported. CPT also contributes to significant and rapid reductions in suicide ideation among people diagnosed wit...

What is the current status of trial NCT04690582?

This trial is currently completed. It is a NA study. The enrollment target is 157 participants. The study started on 2021-01-15. Estimated completion is 2023-12-31.

What conditions does trial NCT04690582 study?

This clinical trial studies the following conditions: PTSD, Suicidal Ideation, Suicide, Attempted.

What interventions are being tested in trial NCT04690582?

The interventions under investigation include: Cognitive Processing Therapy (CPT) (BEHAVIORAL), Narrative Assessment (BEHAVIORAL), Crisis Response Plan (CRP) (BEHAVIORAL), Safety Planning Intervention (SPI) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04690582?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04690582 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04690582's enrollment target sits among peer trials

157 43rd of 154 higher than 112 of 154 other PTSD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05052541 · 157 participants · Phase 3

    Safety and Efficacy of Oral Cannabis in Chronic Spine Pain

  • NCT05076942 · 157 participants · Phase 2

    Groningen International Study on Sentinel Nodes in Vulvar Cancer-III

  • NCT06396598 · 157 participants · NA

    Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer

  • NCT06655246 · 157 participants · Phase 1

    A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04690582, the US trial registry maintained by the National Library of Medicine. NCT04690582 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.